Chiadi U. Onyike, MD, MHS Johns Hopkins Neuropsychiatry · Neuropsychiatry in Prague (1887-1921)....
-
Upload
hoangthuan -
Category
Documents
-
view
215 -
download
2
Transcript of Chiadi U. Onyike, MD, MHS Johns Hopkins Neuropsychiatry · Neuropsychiatry in Prague (1887-1921)....
Disclosure: PI, Baltimore site of multicenter trial of memantine for
behavioral frontotemporal dementia ▪ Results published: The Lancet Neurology, 12(2), 149–156.
PI, Baltimore site of multicenter trial of LMTM for behavioral frontotemporal dementia
Content: Spectrum of non-Alzheimer neurodegenerative diseases Their features Their management
A teacher of 58 developed dysnomia and decline in spelling ability, comprehension of reading and conversation, and singing ability. Attention, planning/organization and self care were impaired, and he exhibited child-like behavior and loss of etiquette (eating some meals with his fingers). He developed anxiety. Two years into the illness, a neurologist suspected dementia. MMSE score was 27 points and the neurological exam was normal. Brain MRI showed temporal lobe atrophy.
Neuropsychological testing 3 years later showed MMSE = 28, and impaired memory and learning, marked dysnomia, and poor word knowledge with paraphasias and regularization spelling errors. Behavior was impulsive and obstinate. Eating was gluttonous. A year later MMSE = 29. Further decline in word and object knowledge was noted…
High prevalence 682 with MCI (n=138) or
dementia (n=270)
43% of MCI ▪ 20% depression ▪ 15% apathy ▪ 15% irritability
75% of dementia patients ▪ 35% apathy ▪ 32% depression ▪ 30% agitation/aggression
Incidence N (%), N = 61 Mean severity score (SD)
Delusions 17 (27.9) 4.1 (3.6)
Apathy 13 (21.3) 5.6 (3.6)
Aberrant motor behavior 13 (21.3) 3.7 (2.5)
Irritability 12 (19.7) 3.8 (4.0)
Depression 11 (18.0) 4.7 (3.2)
Hallucinations 10 (16.4) 2.9 (1.3)
Agitation/aggression 10 (16.4) 6.4 (3.8)
Anxiety 9 (14.8) 3.6 (2.6)
Disinhibition 6 (9.8) 2.0 (0.9)
Elation 0 (0) N/A
Is it “memory loss”?
Is it just cognition?
What about? Depression/anxiety Paranoia and delusions Hallucinations Abnormalities of judgment
and social conduct Compulsions
Alzheimer disease, AD Most common cause
Cerebrovascular disease, CVD Genetic varieties particularly
Frontotemporal degeneration, FTD 1:1 or greater ratio FTD:AD below age 50
Lewy body disease Uncommon before age 65
Traumatic brain injury, TBI
HIV/AIDS dementia Prevalence decreased since HAART
Alcohol-related dementia Controversial; due to nutritional deficiency?
Huntington disease, HD Among the commonest below age 35
Prion dementias, e.g., CJD Fulminant progression
Multiple sclerosis, MS
Normal Pressure Hydrocephalus
Left: The Prague Asylum, with a view of the tower of St. Catharine Monastery. Right: Arnold Pick (1851-1924); Professor of Psychiatry and Neuropathology and Chair of Neuropsychiatry in Prague (1887-1921). He described the presenile focal dementias and aphasias that would became known as ‘Pick’s disease’.
Source: Kertesz and Kavlach, 1996
Historical timeline
“It’s hallmarks are progressive decline in
[conduct]: coarsening of temperament, dispositions, judgment, and comportment; dysregulation of emotions, drives and self-control; and disintegration of language and communication… Aphasia syndromes and motor syndromes are also well recognized”
1896 – case study: primary aphasia
1911 – “Pick” bodies
1923/26 – “Picks disease”
1974/75 – Types A, B and C
1975 – Semantic aphasia
1982 – Primary progressive aphasia
1986 – 1st conference, Lund, Sweden
1994 & 98 – Lund-Manchester criteria
1998 – 1st genetic locus (MAPT)
2006 & 09 – TDP43 & FUS discovery
2011 – International criteria
2011 – 7th genetic locus (C9orf72)
Definition
Onyike et al., 2011
Insidious deterioration
Behavioral disinhibition and asocial behavior
Inertia and apathy
Loss of empathy/sympathy
Perseveration, stereotypies and compulsions
Hyperorality, hyperphagia and/or stereotyped eating habits
Executive dysfunction
Focal abnormality on brain imaging
Causal mutation
Peak age of onset 53 – 58; range 21 – 75…
Prevalence: 18 – 38 per 100,000
Incidence: 3 – 4 per 100,000
Life expectancy: 8 –10 years; ~3 years for FTD-ALS
M>>F in most reports
AD:FTD ratio <2 below age 65
Familial in >40%; hereditary in 10-20%
Phenotypic heterogeneity reflects biologic heterogeneity
Syndrome to disease (phenotype:pathology) correlation is imperfect
Syndrome to genotype correlation is also imperfect
Syndromes not shown include affective and psychotic presentations
Gender Onset Clinic Death Features FamHx Tau Ubiq TDP43 Diagnosis
Case 1 F 21 22 25 DEP, COGIMP None + - N FTD17
Case 2 M 28 33 37 SCHIZ None - + + FTD-MND
Case 3 M ? 37 46 APATH/DISIN ? - - ? DLDH
Case 4 M 34 39 41 BIPOLAR None - + N FTD-U
Case 5 M 35 39 43 SCHIZ None - + + FTD-MND
Case 6 M 37 40 44 DEP/APATH YOD - + + FTD-U (PGRN)
Case 7 M 38 43 45 SCHIZ FTD-MND - + ? FTD-ID
Case 8 M 45 46 49 APATH FTD17 + + FTD17
Case 9 M 43 49 61 COGIMP None - + + FTD-ID
Case 10 F ? 50 63 COGIMP YOD + - N FTD17
Case 11 M 45 50 63 COGIMP/APATH MND* - + ? FTD-U
Case 12 M ? 51 62 COGIMP FTD17 + - N FTD17
Case 13 F 50 53 64 COGIMP LOD - + ? FTD-U
Case 14 F 49 55 66 COGIMP None - + + FTD-ID
Case 15 M 56 57 59 COGIMP/PSP AD + - N PSP
Case 16 M 58 59 60 DISIN/COGIMP None - + + FTD-ID
Case 17 F 59 62 65 COGIMP None - + + FTD-MND
Implications for clinical syndromes
Different clinical syndromes may represent the same disease state
Memory is not necessarily a central characteristic of dementia
Thus arise questions about: Dementia definitions How clinical phenomena relate to
diseases Traditional professional boundaries (i.e.,
cognitive vs. behavioral; “organic” vs. “non-organic”)
“I wish it would dawn upon engineers that, in order to be an engineer, it is not enough to be an engineer”
Jose Ortega y Gasset (Toward a Philosophy of History, 1941)
History:
Unusual age at onset
Puzzling “atypical” features
Family history of dementia,
parkinsonism, motor disorder
Unusual prodrome, e.g., sleep problem
Rapid progression
Mental state:
Poor insight
Apathy/indifference
Compulsions without obsessions
Early hallucinations and/or paranoia
Cognitive state
Predominance of abnormal speech
Unusually pronounced loss of skills
Visual complaints (other than
hallucinations)
Motor examination
Abnormal posture and movement
Frequent falls at early stage
Frequent jerking
Progressive motor weakness
Poor coordination
Left-right asymmetry
Disease/disorder Phenotype Onset Features
AD Apathy, depression, anxiety, amnesia, dysexecutive
65+ cognition; global atrophy; diffuse EEG slowing
FTD conduct, impulsive, dysexecutive, aphasia
45+ cognition; focal EEG slowing; focal atrophy
Vascular dementia Dysexecutive, affective disorder, psychomotor slowing, CVD
>60 cognition; neurological signs; infarcts and gliosis on MRI
DLB Hallucinations, paranoia, amnesia, parkinsonism
>70 cognition; global atrophy; diffuse EEG slowing
Major depression Intermittent depression with apathy and anhedonia
<30 Normal cognition; normal EEG; no atrophy
OCD Obsessions, compulsions and anxiety
<30 Normal insight, cognition, EEG; no atrophy
Bipolar disorder Intermittent mania and depression
<35 Normal cognition; no atrophy
Schizophrenia Intermittent or chronic psychosis <30 Youth onset; chronic status; stable cognition; no atrophy
Personality disorder Sociopathic; compulsive behavior <18 Lifelong (+/- developmental); stable cognition; variable EEG; no atrophy
History
Clinical examination
“Bedside” scales
Laboratory tests
Neuropsychology assessment
Blood/serum assays
EEG
Brain MRI
Brain SPECT
Brain PET
Genetic analysis
Jun 2008 Oct 2008 Jan 2009 Mar 2009 Jun 2009 Sep 2009
MMSE 29 30 27 28 27 30
3MS 90 98 91 -- -- --
CDR 1.0 1.0 -- 1.0 1.0 1.0
Sep 2009: Poor CVLT Category-cued fluency = 5 Digit span (reverse) = 4 BNT (15-item) = 10 CGIC: “Mild decline”
Problem Role Intervention
Disease/disorder Diagnose Provide evaluation, direct investigation, make referrals
Distressing or offensive symptom(s)
Provide relief Make prescriptions
Handicaps, crises Solve problems Manage crises and psychosocial/rehabilitative care
Demoralization, stress Guidance Provide clarification, support and direction
The Alzheimer Association at www.alz.org or www.alz.org/maryland for the local chapter
Association for Frontotemporal dementias at www.ftd-picks.org
Websites at JHH, Columbia, UCSF, the Mayo Clinics, U of Pennsylvania…
BOOKS: The 36 Hour Day - Nancy Mace and Peter Rabins What if it is not Alzheimer’s: A Caregiver’s Guide to Dementia - Lisa and Gary
Radin, editors The Banana Lady and Other Stories of Curious Behavior - Andrew Kertesz The Family That Couldn’t Sleep: A Medical Mystery - D.T. Max
Drug(s)
Pluripotent cells Drosophila C. Elegans Zebra fish Mouse
Clinical trials
Stratified by: AB42/tau Tau TDP-43 FUS
Cases & cohorts
Recruitment of centers & regional networks
Cohort(s)
Data and tissue capture in registry & biobank
Onyike CU, 2014. Strategies for increasing global research in familial FTLD. International EFE fFTLD conference lecture, San Francisc0. Nov. 2014.
Cases & cohorts
Recruitment of centers & regional networks
Cohort(s)
Data and tissue capture in registry & biobank
Enrollment Registration
Known Known
New
New
New
Cohort
Case identification
Onyike CU. EFE fFTLD conference lecture, San Francisc0. Nov. 2014.
Neuropsychiatry: Peter Rabins, MD Campbell Sullivan, PhD Mary Anne Wylie, RN Rebecca Rye, RN Kate Hicks, MPH Kelly Sloane, MS-III Kalyani Kansal Alexa Minc
Cognitive Neurology: Argye Hillis, MD Marilyn Albert, PhD
Neuropathology Juan Troncoso, MD Olga Pletnikova, MD
Neuroscience Phil Wong, PhD
Packard Center for ALS Bryan Traynor, MD, PHD Jeff Rothstein, MD, PhD Nick Maragakis, MD Lora Clawson, RN Richard Kimball, RN